Lv01
0 积分 2025-02-25 加入
Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway
2小时前
待确认
TREM2 scFv‐Engineering Escherichia coli Displaying Modulation of Macrophages to Boost Cancer Radio‐Immunotherapy
2小时前
已完结
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
3小时前
已完结
AP2M1 as the potential biomarker for prediction of the response of atopic dermatitis to Dupilumab therapy: Multi-omics analysis and evidence
1天前
已完结
Selective activation of IFNγ–ipilimumab enhances the therapeutic effect and safety of ipilimumab
2天前
已完结
The hallmarks of cancer immune evasion
6天前
已完结
Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling
7天前
已完结
A comprehensive review of immune checkpoint inhibitors for cancer treatment
9天前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
1个月前
已完结
P0848 Engineering and Development of a Novel Bispecific Antibody Targeting both TL1A and α4β7 for the Treatment of IBD
1个月前
已完结
皖公网安备34019202002308
